Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial

Annals of the New York Academy of Sciences

Volumn 1268, Issue 1, 2012, Pages 72-78

  Southerland, Andrew M ^a   Johnston, Karen C ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Glucose; Hemorrhage; Hyperglycemia; Stroke; T PA; Thrombolysis

Indexed keywords

ALTEPLASE; GLUCOSE; INSULIN; PLACEBO;

ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; NONHUMAN; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; STROKE; TREATMENT OUTCOME;

EID: 84866526254     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06731.x     Document Type: Article

References (60)

1. Roger, V.L., A.S. Go, D.M. Lloyd-Jones, et al 2012. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125: e2-e220.
2. Howard, G. & D.C. Goff 2012. Population shifts and the future of stroke: forecasts of the future burden of stroke. Ann. N.Y. Acad. Sci. 1268: 14-20. This volume.
3. Kissela, B.M., J. Khoury, D. Kleindorfer, et al 2005. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 28: 355-359.
4. Gentile, N.T., M.W. Seftchick, T. Huynh, et al 2006. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad. Emerg. Med. 13: 174-180.
5. Williams, L.S., J. Rotich, R. Qi, et al 2002. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59: 67-71.
6. Capes, S.E., D. Hunt, K. Malmberg, et al 2001. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32: 2426-2432.
7. Anderson, R.E., W.K. Tan, H.S. Martin, et al 1999. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 30: 160-170.
8. Kawai, N., R.F. Keep & A.L. Betz 1997. Hyperglycemia and the vascular effects of cerebral ischemia. Acta Neurochir. Suppl. 70: 27-29.
9. Bomont, L. & E.T. MacKenzie 1995. Neuroprotection after focal cerebral ischaemia in hyperglycaemic and diabetic rats. Neurosci. Lett. 197: 53-56.
10. Yip, P.K., Y.Y. He, C.Y. Hsu, et al 1991. Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology 41: 899-905.
11. Chew, W., J. Kucharczyk, M. Moseley, et al 1991. Hyperglycemia augments ischemic brain injury: in vivo MR imaging/spectroscopic study with nicardipine in cats with occluded middle cerebral arteries. AJNR Am. J. Neuroradiol. 12: 603-609.
12. de Courten-Myers, G., R.E. Myers & L. Schoolfield 1988. Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke 19: 623-630.
13. Bruno, A., T.A. Kent, B.M. Coull, et al 2008. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 39: 384-389.
14. Johnston, K.C., C.E. Hall, B.M. Kissela, et al 2009. Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke 40: 3804-3809.
15. Gray, C.S., A.J. Hildreth, P.A. Sandercock, et al 2007. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurology 6: 397-406.
16. http://www.shinetrial.com [Accessed on 6 August 2012]. [Accessed on 6 August 2012].
17. Hacke, W., G. Donnan, C. Fieschi, et al 2004. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363: 768-774.
18. Johnston, K.C., A.F. Connors Jr., D.P. Wagner, et al 2000. A predictive risk model for outcomes of ischemic stroke. Stroke 31: 448-455.
19. Putaala, J., T. Sairanen, A. Meretoja, et al 2011. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke. Cerebrovasc. Dis. 31: 83-92.
20. Saver, J.L. 2007. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke 38: 2279-2283.
21. Brown, D.L., W.G. Barsan, L.D. Lisabeth, et al 2005. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann. Emerg. Med. 46: 56-60.
22. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. 1995. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333: 1581-1587.
23. Hacke, W., M. Kaste, E. Bluhmki, et al 2008. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359: 1317-1329.
24. Wahlgren, N., N. Ahmed, A. Davalos, et al 2007. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369: 275-282.
25. Strbian, D., T. Sairanen, A. Meretoja, et al 2011. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology 77: 341-348.
26. Southerland, A.M., S. Malik & K.C. Johnston 2011. Symptomatic ICH and outcomes in patients after IV tPA: a business of risk or risky business? Neurology 77: 315-316.
27. Lou, M., A. Safdar, M. Mehdiratta, et al 2008. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology 71: 1417-1423.
28. de Courten-Myers, G.M., M. Kleinholz, K.R. Wagner, et al 1989. Fatal strokes in hyperglycemic cats. Stroke 20: 1707-1715.
29. de Courten-Myers, G.M., M. Kleinholz, P. Holm, et al 1992. Hemorrhagic infarct conversion in experimental stroke. Ann. Emerg. Med. 21: 120-126.
30. Prado, R., M.D. Ginsberg, W.D. Dietrich, et al 1988. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J. Cereb. Blood Flow Metab. 8: 186-192.
31. Kawai, N., R.F. Keep & A.L. Betz 1997. Effects of hyperglycemia on cerebral blood flow and edema formation after carotid artery occlusion in Fischer 344 rats. Acta Neurochir. Suppl. 70: 34-36.
32. Dietrich, W.D., O. Alonso & R. Busto 1993. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 24: 111-116.
33. Ginsberg, M.D., R. Prado, W.D. Dietrich, et al 1987. Hyperglycemia reduces the extent of cerebral infarction in rats. Stroke 18: 570-574.
34. Nedergaard, M., A. Gjedde & N.H. Diemer 1987. Hyperglycaemia protects against neuronal injury around experimental brain infarcts. Neurol. Res. 9: 241-244.
35. Zasslow, M.A., R.G. Pearl, L.M. Shuer, et al 1989. Hyperglycemia decreases acute neuronal ischemic changes after middle cerebral artery occlusion in cats. Stroke 20: 519-523.
36. Kraft, S.A., C.P. Larson Jr., L.M. Shuer, et al 1990. Effect of hyperglycemia on neuronal changes in a rabbit model of focal cerebral ischemia. Stroke 21: 447-450.
37. Combs, D.J., R.J. Dempsey, S. Kumar, et al 1990. Focal cerebral infarction in cats in the presence of hyperglycemia and increased insulin. Metab. Brain Dis. 5: 169-178.
38. Voll, C.L. & R.N. Auer 1988. The effect of postischemic blood glucose levels on ischemic brain damage in the rat. Ann. Neurol. 24: 638-646.
39. Wei, J. & M.J. Quast 1998. Effect of nitric oxide synthase inhibitor on a hyperglycemic rat model of reversible focal ischemia: detection of excitatory amino acids release and hydroxyl radical formation. Brain Res. 791: 146-156.
40. Wei, J., N.C. Huang & M.J. Quast 1997. Hydroxyl radical formation in hyperglycemic rats during middle cerebral artery occlusion/reperfusion. Free Radic. Biol. Med. 23: 986-995.
41. Quast, M.J., J. Wei & N.C. Huang 1995. Nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperglycemic rats. Brain Res. 677: 204-212.
42. Won, S.J., X.N. Tang, S.W. Suh, et al 2011. Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production. Ann. Neurol. 70: 583-590.
43. Tang, J., J. Liu, C. Zhou, et al 2005. Role of NADPH oxidase in the brain injury of intracerebral hemorrhage. J. Neurochem. 94: 1342-1350.
44. Suh, S.W., B.S. Shin, H. Ma, et al 2008. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann. Neurol. 64: 654-663.
45. Simpson, M.A., H.M. Dewey, L. Churilov, et al 2010. Thrombolysis for acute stroke in Australia: outcomes from the Safe Implementation of Thrombolysis in Stroke registry (2002-2008). Med. J. Aust. 193: 439-443.
46. Hill, M.D., A.M. Buchan & Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. 2005. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 172: 1307-1312.
47. Alvarez-Sabin, J., C.A. Molina, J. Montaner, et al 2003. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 34: 1235-1241.
48. Demchuk, A.M., L.B. Morgenstern, D.W. Krieger, et al 1999. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 30: 34-39.
49. Bruno, A., S.R. Levine, M.R. Frankel, et al 2002. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59: 669-674.
50. Kase, C.S., A.J. Furlan, L.R. Wechsler, et al 2001. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 57: 1603-1610.
51. De Silva, D.A., M. Ebinger, S. Christensen, et al 2010. Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. Cerebrovasc. Dis. 29: 14-21.
52. Kent, T.A., V.M. Soukup & R.H. Fabian 2001. Heterogeneity affecting outcome from acute stroke therapy: making reperfusion worse. Stroke 32: 2318-2327.
53. Adams, H.P. Jr., G. del Zoppo, M.J. Alberts, et al 2007. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38: 1655-1711.
54. Adams, H.P. Jr., T.G. Brott, A.J. Furlan, et al 1996. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 94: 1167-1174.
55. Al-Khoury, L. & P.D. Lyden 2004. Intravenous thrombolysis. In Stroke: Pathophysiology, Diagnosis, and Mangaement. J.P. Mohr, D.W. Choi, J.C. Grotta, et al., Eds.: Churchill Livingstone. Philadelphia, 933-934.
56. http://www.jointcommission.org/certification/primary_stroke_centers.aspx [Accessed on 8 August 2012] [Accessed on 8 August 2012]
57. Tilley, B.C., J. Marler, N.L. Geller, et al 1996. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke 27: 2136-2142.
58. Adams, H.P. Jr., J.R. Leclerc, E. Bluhmki, et al 2004. Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc. Dis. 18: 124-129.
59. Silbergleit, R., M.H. Biros, D. Harney, et al 2012. Implementation of the exception from informed consent regulations in a large multicenter emergency clinical trials network: the RAMPART experience. Acad. Emerg. Med. 19: 448-454.
60. Tanne, D., S.E. Kasner, A.M. Demchuk, et al 2002. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 105: 1679-1685.